NIH-funded research R01 grant

Controlled PTEN reduction to help spinal cord nerves regrow after injury

Official title: Regulated PTEN expression to overcome barriers to corticospinal tract regeneration after spinal cord injury

Funded at University of Louisville · NIH-11394619 · Data updated 2026-11-12

A scientist team is testing a way to safely reduce a growth-inhibiting protein (PTEN) in adults with spinal cord injury to help the nerves in the spinal cord regrow and restore movement.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startSeptember 1, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$391,250
NIH project number5R01NS132773-03
Project IDNIH-11394619 on NIH RePORTER

Who could benefit from this research

Could help

Adults with spinal cord injury who could be eligible for a cord-regeneration therapy using AAV-delivered PTEN modulation.

Less likely to help

Patients whose injuries are not compatible with the specific timing or delivery method, or who have contraindications to AAV-based therapies, may not benefit.

What this research studies

This project aims to deliver a therapy using a virus-based system to tune PTEN levels in the corticospinal tract after spinal cord injury. Researchers will study when and how long PTEN should be reduced to promote regrowth without causing harm, and how this interacts with other approaches that digest scar-related molecules. The work will focus on translating these concepts to improve functional recovery in adults with SCI. The study plans careful monitoring of potential side effects and long-term outcomes in a controlled setting.

Why it matters

Potential benefit: If successful, this approach could improve natural nerve regrowth and potentially restore some motor function after spinal cord injury.

How similar studies have gone: Previous work has shown that controlled PTEN modulation can promote axon growth, with ongoing studies evaluating long-term outcomes and safety.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Metcalfe, Mariajose — University of Louisville
  • Study coordinator: Metcalfe, Mariajose

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.